Your browser doesn't support javascript.
loading
Relapses in people with multiple sclerosis treated with cladribine tablets followed for up to 5 years: a plain language summary.
Stefano, Nicola De; Sormani, Maria Pia; Giovannoni, Gavin; Rammohan, Kottil; Leist, Thomas P; Coyle, Patricia K; Dangond, Fernando; Alexandri, Nektaria; Galazka, Andrew.
Afiliação
  • Stefano N; Department of Neurological & Behavioural Sciences, University of Siena, Siena, Italy/Department of Medicine, Surgery & Neuroscience, University of Siena, Siena, Italy.
  • Sormani MP; Department of Health Sciences, University of Genoa & Ospedale Policlinico San Martino IRCCS, Genoa, Italy.
  • Giovannoni G; Blizard Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
  • Rammohan K; Department of Neurology, University of Miami School of Medicine, MS Research Center, Miami, FL, USA.
  • Leist TP; Division of Clinical Neuroimmunology, Jefferson University, Comprehensive MS Center, Philadelphia, PA, USA.
  • Coyle PK; Department of Neurology, Stony Brook University, Stony Brook, NY, USA.
  • Dangond F; EMD Serono Research & Development Institute Inc., Billerica, MA, USA, an affiliate of Merck KGaA.
  • Alexandri N; Merck Healthcare KGaA, Darmstadt, Germany.
  • Galazka A; Merck Healthcare KGaA, Darmstadt, Germany.
Neurodegener Dis Manag ; 12(6): 303-310, 2022 12.
Article em En | MEDLINE | ID: mdl-36017797
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Neurodegener Dis Manag Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Neurodegener Dis Manag Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália